These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22720483)

  • 1. "People with rare cancers get a raw deal in research and care".
    Newlands J
    Nurs Times; 2012 Feb 7-13; 108(6):11. PubMed ID: 22720483
    [No Abstract]   [Full Text] [Related]  

  • 2. Collaboration is key to treating uncommon cancers: scientists and patients champion research in these rare diseases.
    Printz C
    Cancer; 2010 Jun; 116(12):2847-9. PubMed ID: 20564387
    [No Abstract]   [Full Text] [Related]  

  • 3. EU paves way for overseas treatment of rare diseases.
    Santry C
    Health Serv J; 2010 Nov; 120(6231):9. PubMed ID: 21132897
    [No Abstract]   [Full Text] [Related]  

  • 4. Transfer of high cost drugs to NICE risks fragmentation of care of rare diseases.
    Hendriksz CJ; Hughes DA; Mehta AB; Wraith JE; Jones SE; Ramaswami U; Deegan P; Lachmann R; Murphy E; Hiwot T; Vijay SV; Stewart F; Cleary M
    BMJ; 2012 Aug; 345():e5727. PubMed ID: 22923539
    [No Abstract]   [Full Text] [Related]  

  • 5. Who will stand for rare conditions?
    Murray J
    Health Serv J; 2008 Mar; ():16-7. PubMed ID: 18446968
    [No Abstract]   [Full Text] [Related]  

  • 6. The challenge of funding research on rare malignancies.
    Palkhivala A
    J Natl Cancer Inst; 2011 Nov; 103(22):1650-2. PubMed ID: 22025627
    [No Abstract]   [Full Text] [Related]  

  • 7. Genome project aims to transform treatment of cancer and rare diseases.
    Godlee R
    BMJ; 2014 Aug; 349():g4972. PubMed ID: 25085691
    [No Abstract]   [Full Text] [Related]  

  • 8. A no-deal Brexit will be detrimental to people with rare diseases.
    Tischkowitz M; Power B; Slater G
    Lancet; 2021 Jan; 397(10268):20. PubMed ID: 33316208
    [No Abstract]   [Full Text] [Related]  

  • 9. A patient-researcher partnership for rare cancer research.
    Staniszewka S
    Nat Med; 2020 Feb; 26(2):164-165. PubMed ID: 32042195
    [No Abstract]   [Full Text] [Related]  

  • 10. [ERDITI, The European Rare Diseases Therapeutic Initiative: a public-private partnership is promoting research on new treatments for rare diseases].
    Gilgenkrantz S; Borensztein P
    Med Sci (Paris); 2006 Jan; 22(1):84-6. PubMed ID: 16386228
    [No Abstract]   [Full Text] [Related]  

  • 11. [Round table 4. Speeding new therapeutic approaches for rare diseases: do we need new economical models or financial tools?].
    Med Sci (Paris); 2014 Apr; 30 Spe(1):47-53. PubMed ID: 24755179
    [No Abstract]   [Full Text] [Related]  

  • 12. Specialized teams or specialist networks for rare cancers?
    Sandrucci S; Gatta G; Trama A; Dei Tos AP; Casali PG
    Eur J Surg Oncol; 2015 Sep; 41(9):1115-7. PubMed ID: 25936223
    [No Abstract]   [Full Text] [Related]  

  • 13. Patients often go without effective new treatments, especially in rare disease patient populations where profit potential is limited.
    Bloom BE
    Contemp Clin Trials; 2011 Mar; 32(2):151-2. PubMed ID: 21238613
    [No Abstract]   [Full Text] [Related]  

  • 14. Patient advocacy in Diamond Blackfan anemia: facilitating translational research and progress towards the cure of a rare disease.
    Arturi MC
    Semin Hematol; 2011 Apr; 48(2):75-80. PubMed ID: 21435503
    [No Abstract]   [Full Text] [Related]  

  • 15. Do we need randomised trials for rare cancers?
    Prasad V; Oseran A
    Eur J Cancer; 2015 Jul; 51(11):1355-7. PubMed ID: 25963018
    [No Abstract]   [Full Text] [Related]  

  • 16. Should clinical trials be approached differently for rare cancers?
    Olver I
    Future Oncol; 2016 May; 12(10):1207-9. PubMed ID: 26939845
    [No Abstract]   [Full Text] [Related]  

  • 17. International rare cancers initiative.
    Keat N; Law K; Seymour M; Welch J; Trimble T; Lascombe D; Negrouk A
    Lancet Oncol; 2013 Feb; 14(2):109-10. PubMed ID: 23369681
    [No Abstract]   [Full Text] [Related]  

  • 18. Uncommon ventures launch to tackle uncommon diseases.
    Dolgin E
    Nat Med; 2013 Aug; 19(8):950-1. PubMed ID: 23921728
    [No Abstract]   [Full Text] [Related]  

  • 19. A quarter of patients with rarer cancers see GPs several times before referral.
    Mayor S
    BMJ; 2016 Feb; 352():i1198. PubMed ID: 26929277
    [No Abstract]   [Full Text] [Related]  

  • 20. To make progress in rare cancers, patients must lead the way.
    Dockser Marcus A
    J Clin Oncol; 2009 Jun; 27(16):2575-7. PubMed ID: 19414666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.